ABSTRACT
INTRODUCTION
Occasionally, elements of diverse histogenetic and molecular characteristics are noted within one tumoral mass.
Diagnosis of a neoplasm composed of more than one tumoral tissue can be extremely challenging, so is the treatment. Shuch, et al. [1] there is a great confusion in the scientific literature regarding this topic. Sarcomatoid carcinoma, carcinosarcoma, mixed tumor, collision tumor, hybrid tumor, combined tumor, tumor transformation, biphasic tumor, tumor with metaplasia, etc, are often misclassified. This is an attempt to gain a better understanding of this issue.
LITERATURE REVIEW AND CASES
neoplasm [3, 4] . b) Some collided tumors are metastases from other sites [3] [4] [5] .
c) The collision is coincidental.
2-Tumors with biphasic differentiation such as sarcomatoid carcinoma (SC) which represents a carcinoma
with a sarcomatous component [6] . The carcinomatous and the sarcomatoid component are intermixed. It has been published, based on X-chromosome inactivation pattern and TP53 mutation studies, that in some sarcomatoid carcinomas both elements, epithelial and mesenchymal, arise from the same cell, and that the initial malignancy is a carcinoma which suffers sarcomatous transformation, keeping the mutation profile of the initial epithelial malignancy [7] . Sarcomatoid carcinomas are truly carcinomas, which have lost several of their epithelial characteristics and underwent mesenchymal differentiation. These tissues have the same genotype but express multi-phenotypic differentiation. Therefore, immunochemistry has a little value, making the final diagnosis difficult [5] .
This category includes sarcomas with epithelial differentiation such as biphasic synovial sarcoma.
Theories for explanation of biphasic tumors:
a) The epithelial and mesenchymal components arise from the same cell.
b) The sarcomatoid component of sarcomatoid carcinoma may arise from a clone with lack of differentiation originated from the initial carcinoma [1] [2] [3] . Conversely, the epithelioid component of these sarcomas may arise from a cell with lack of differentiation originated from the original sarcoma.
c) A mutagenic factor may interact with the tumoral tissue inducing a different type of tumor [8, 9] . c) A growth factor produced by one tumor, may induce the development of the other [10] .
A case of a mandibular sarcomatoid carcinoma associated with a collision keratocystic odontogenic tumor is described below and illustrates these two types of hybrid neoplasms.
Sarcomatoid carcinoma (SC) is highly malignant neoplasm that contain cells with properties of epithelial and mesenchymal tumors. It is an extremely rare and aggressive entity.
Keratocystic odontogenic tumor is a destructive, cystic odontogenic condition with 30% recurrence rate. The typical clinical/radiographic presentation of KCOT is that of an expansive, radiolucent, multilocular lesion, usually located on the posterior mandible and often associated with a non-erupted tooth. Based on the KCOT genetics and behavior, WHO classified this lesion as a tumor.
A 90 year old male presented, with generalized weakness, to the Oral and Maxillofacial Surgery Clinic, for evaluation of a recently appeared mandibular nodule. His medical history was relevant for prostate carcinoma treated years before, and believed to be in remission, diabetes and hypertension.
Upon oral examination, a pedunculated lesion with dark reddish discoloration, protruding from the edentulous alveolar ridge of the anterior mandible was seen. This mass bled easily and measured 1. A diagnosis of sarcomatoid carcinoma and collision with keratocystic odontogenic tumor was rendered.
The patient was treated by wide excision, marginal anterior resection and radiation therapy. A percutaneous Endoscopic Gastrostomy tube for nutrition was placed. The prognosis is extremely poor.
3-Transformed tumor.
A third category is that of a neoplasm that suffers complete transformation into a tumor with a different type of tissue, a totally different genotype.
The exact mechanism of the tumor's transformation is unclear. Gulbranson, et al. [11] the theories are:
1-There were two pre-existent cells types in the area.
2-They differentiated from a common oligopotential cell.
3-A known theory states that these cases originate as a tissue modification, due to severe chronic environmental stimuli [11] . The cells of a tumor show plasticity when they are exposed to tumor factors.
As an example, a case of an odontogenic carcinoma which underwent change into a leiomyosarcoma is shown.
The clinical diagnosis of this case was pyogenic granuloma, located in the area of a molar extracted due to an "apical cyst" (Fig # 7 ) Initial histology exhibited a large population of proliferating epithelial neoplastic cells
showing an odontogenic pattern. Hyperchromatism, pleomorphism and mitosis were seen. A diagnosis of odontogenic carcinoma was rendered. (Fig # 8 A) Almost immediately after the surgical treatment, the tumor recurred with a different histopathology. Spindle and pleomorphic, mesenchymal-looking cells.
Immunohistochemistry showed: EMA (epithelial membrane antigen) negative, pankeratin: negative. Desmin (Muscle marker): was strongly positive in large bizarre cells supporting the diagnosis of myoblastic differentiation.
( Fig # 8 B) No identifiable odontogenic tissue was found in numerous sections examined.
Final diagnosis: Rhabdomyoblastic differentiation of an odontogenic carcinoma. This tumor differed from carcinosarcoma and sarcomatoid carcinoma because the mesenchymal and carcinomatoid components, were never intermixed. The initial tumor was a carcinoma and the recurrence was a sarcoma.
4-Malignization:
a benign condition, a tumor or a cyst, gives origin to a malignant neoplastic change. The occurrence of a malignancy arising from the lining of odontogenic cysts is well known. The accepted theory is that there is oncogenic multi-potentiality within the odontogenic epithelium. [12] [13] [14] a case of squamous cell carcinoma clearly arising in keratocystic odontogenic tumor ( KCOT) (Figures # 9,10 ) is also shown in this article.
5-Combined tumor (carcinosarcoma)
is a condition that exhibits a mixture of morphologic, molecular, histopathological and genetic characteristics of more than one tissue, within the same topographical area and shows different tumoral tissues admixed among them [6] . They are composed of a carcinoma and a sarcoma and they are classified as carcinosarcomas.
The theories that explain the formation of combined tumor are: a) They may arise from the same pluri-potential cell. However, in some cases, different tissues are derived from different precursor cells [6] .
b) The stem cell hypothesis which states that tumors originate from stem cells of the area. They differentiate in diverse progenies of cells that are able to form various types of tissues and intermixed tumors [3] .
according to the phases of odontogenesis. Inductive influences of odontogenic epithelium over mesenchymal tissue and vice versa are occurring during the process. [14, 15] 
CONCLUSIONS
Diagnosis of a neoplasm composed of more than one tumoral tissue can be extremely challenging, so is the treatment. There is a great confusion in the scientific literature regarding the classification of tumors with elements of diverse histogenetic and molecular characteristics and they are often misclassified. This is an attempt, illustrated with several examples of these types of tumors from the gnathic system, to gain a better understanding of this issue.
One of the cases represents a sarcomatoid carcinoma, which at the same time, is a collision tumor. While, sarcomatoid carcinoma is already a very rare event, its presentation together with another tumor displaying different cytogenetic and molecular characteristics, makes this case even more bizarre. The radiologic, clinical, and microscopic findings of unusual hybrid and complex tumors is always a challenge.
The prognosis of a collision tumor is determined by the higher-grade element and therefore, it should be treated as the most aggressive component. Due to the relatively less aggressive nature of the KCOT, this condition was treated as sarcomatoid carcinoma. The prognosis is poor. As the best of our knowledge, this is the first report of a collision tumor between a sarcomatoid carcinoma and a keratocystic odontogenic tumor. It is critical to understand these types of tumors, for correct diagnosis, staging and treatment
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